nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Tafluprost—PTGS2—muscle cancer	0.0516	1	CrCbGaD
Travoprost—Ocular discomfort—Methotrexate—muscle cancer	0.0296	0.0312	CcSEcCtD
Travoprost—Drug hypersensitivity—Doxorubicin—muscle cancer	0.0145	0.0153	CcSEcCtD
Travoprost—Musculoskeletal pain—Vincristine—muscle cancer	0.014	0.0148	CcSEcCtD
Travoprost—Prostatic disorder—Doxorubicin—muscle cancer	0.0137	0.0144	CcSEcCtD
Travoprost—Skin discolouration—Etoposide—muscle cancer	0.0124	0.0131	CcSEcCtD
Travoprost—Inflammation—Etoposide—muscle cancer	0.0116	0.0122	CcSEcCtD
Travoprost—Skin hyperpigmentation—Methotrexate—muscle cancer	0.0113	0.0119	CcSEcCtD
Travoprost—Lacrimation—Doxorubicin—muscle cancer	0.00991	0.0104	CcSEcCtD
Travoprost—Skin hyperpigmentation—Doxorubicin—muscle cancer	0.00979	0.0103	CcSEcCtD
Travoprost—Keratitis—Doxorubicin—muscle cancer	0.00898	0.00947	CcSEcCtD
Travoprost—Dysuria—Vincristine—muscle cancer	0.00813	0.00858	CcSEcCtD
Travoprost—Dermatitis atopic—Doxorubicin—muscle cancer	0.00787	0.0083	CcSEcCtD
Travoprost—Pharyngitis—Dactinomycin—muscle cancer	0.00773	0.00816	CcSEcCtD
Travoprost—Depression—Vincristine—muscle cancer	0.00773	0.00815	CcSEcCtD
Travoprost—Scotoma—Doxorubicin—muscle cancer	0.00767	0.00809	CcSEcCtD
Travoprost—Skin discolouration—Methotrexate—muscle cancer	0.00745	0.00785	CcSEcCtD
Travoprost—Bone disorder—Methotrexate—muscle cancer	0.00745	0.00785	CcSEcCtD
Travoprost—Herpes simplex—Methotrexate—muscle cancer	0.0073	0.0077	CcSEcCtD
Travoprost—Dysphonia—Doxorubicin—muscle cancer	0.00708	0.00747	CcSEcCtD
Travoprost—Inflammation—Methotrexate—muscle cancer	0.00694	0.00731	CcSEcCtD
Travoprost—Urinary tract disorder—Vincristine—muscle cancer	0.00688	0.00725	CcSEcCtD
Travoprost—Connective tissue disorder—Vincristine—muscle cancer	0.00684	0.00721	CcSEcCtD
Travoprost—Urethral disorder—Vincristine—muscle cancer	0.00683	0.0072	CcSEcCtD
Travoprost—Erythema—Dactinomycin—muscle cancer	0.00678	0.00715	CcSEcCtD
Travoprost—Cardiac disorder—Vincristine—muscle cancer	0.00646	0.00681	CcSEcCtD
Travoprost—Bone disorder—Doxorubicin—muscle cancer	0.00645	0.0068	CcSEcCtD
Travoprost—Skin discolouration—Doxorubicin—muscle cancer	0.00645	0.0068	CcSEcCtD
Travoprost—Herpes simplex—Doxorubicin—muscle cancer	0.00632	0.00667	CcSEcCtD
Travoprost—Lacrimation increased—Doxorubicin—muscle cancer	0.00632	0.00667	CcSEcCtD
Travoprost—Angiopathy—Vincristine—muscle cancer	0.00632	0.00666	CcSEcCtD
Travoprost—Ill-defined disorder—Dactinomycin—muscle cancer	0.00629	0.00664	CcSEcCtD
Travoprost—Infestation NOS—Etoposide—muscle cancer	0.00628	0.00662	CcSEcCtD
Travoprost—Infestation—Etoposide—muscle cancer	0.00628	0.00662	CcSEcCtD
Travoprost—Mediastinal disorder—Vincristine—muscle cancer	0.00628	0.00662	CcSEcCtD
Travoprost—Malaise—Dactinomycin—muscle cancer	0.00612	0.00645	CcSEcCtD
Travoprost—Mental disorder—Vincristine—muscle cancer	0.0061	0.00643	CcSEcCtD
Travoprost—Inflammation—Doxorubicin—muscle cancer	0.00601	0.00633	CcSEcCtD
Travoprost—Musculoskeletal pain—Doxorubicin—muscle cancer	0.0059	0.00622	CcSEcCtD
Travoprost—Back pain—Vincristine—muscle cancer	0.00586	0.00618	CcSEcCtD
Travoprost—Myalgia—Dactinomycin—muscle cancer	0.00578	0.00609	CcSEcCtD
Travoprost—Dermatitis contact—Doxorubicin—muscle cancer	0.00576	0.00607	CcSEcCtD
Travoprost—Discomfort—Dactinomycin—muscle cancer	0.00571	0.00602	CcSEcCtD
Travoprost—Urinary tract disorder—Etoposide—muscle cancer	0.00557	0.00587	CcSEcCtD
Travoprost—Oedema—Dactinomycin—muscle cancer	0.00554	0.00584	CcSEcCtD
Travoprost—Urethral disorder—Etoposide—muscle cancer	0.00553	0.00583	CcSEcCtD
Travoprost—Infection—Dactinomycin—muscle cancer	0.0055	0.0058	CcSEcCtD
Travoprost—Vertigo—Vincristine—muscle cancer	0.00545	0.00574	CcSEcCtD
Travoprost—Dry eye—Doxorubicin—muscle cancer	0.00538	0.00567	CcSEcCtD
Travoprost—Eye disorder—Etoposide—muscle cancer	0.00527	0.00556	CcSEcCtD
Travoprost—Cardiac disorder—Etoposide—muscle cancer	0.00523	0.00552	CcSEcCtD
Travoprost—Hypertension—Vincristine—muscle cancer	0.00523	0.00552	CcSEcCtD
Travoprost—Myalgia—Vincristine—muscle cancer	0.00516	0.00544	CcSEcCtD
Travoprost—Angiopathy—Etoposide—muscle cancer	0.00512	0.0054	CcSEcCtD
Travoprost—Immune system disorder—Etoposide—muscle cancer	0.00509	0.00537	CcSEcCtD
Travoprost—Mediastinal disorder—Etoposide—muscle cancer	0.00508	0.00536	CcSEcCtD
Travoprost—Abnormal vision—Doxorubicin—muscle cancer	0.00508	0.00536	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00504	0.00532	CcSEcCtD
Travoprost—Oedema—Vincristine—muscle cancer	0.00495	0.00522	CcSEcCtD
Travoprost—Infection—Vincristine—muscle cancer	0.00491	0.00518	CcSEcCtD
Travoprost—Nervous system disorder—Vincristine—muscle cancer	0.00485	0.00512	CcSEcCtD
Travoprost—Dysgeusia—Etoposide—muscle cancer	0.00481	0.00507	CcSEcCtD
Travoprost—Fatigue—Dactinomycin—muscle cancer	0.00477	0.00503	CcSEcCtD
Travoprost—Back pain—Etoposide—muscle cancer	0.00475	0.00501	CcSEcCtD
Travoprost—Pain—Dactinomycin—muscle cancer	0.00473	0.00499	CcSEcCtD
Travoprost—Eye pain—Doxorubicin—muscle cancer	0.00468	0.00494	CcSEcCtD
Travoprost—Hypotension—Vincristine—muscle cancer	0.00462	0.00487	CcSEcCtD
Travoprost—Feeling abnormal—Dactinomycin—muscle cancer	0.00456	0.00481	CcSEcCtD
Travoprost—Ill-defined disorder—Etoposide—muscle cancer	0.00456	0.0048	CcSEcCtD
Travoprost—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00453	0.00477	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00451	0.00475	CcSEcCtD
Travoprost—Malaise—Etoposide—muscle cancer	0.00443	0.00467	CcSEcCtD
Travoprost—Vertigo—Etoposide—muscle cancer	0.00441	0.00465	CcSEcCtD
Travoprost—Abdominal pain—Dactinomycin—muscle cancer	0.00438	0.00462	CcSEcCtD
Travoprost—Cough—Etoposide—muscle cancer	0.00428	0.00452	CcSEcCtD
Travoprost—Gastrointestinal disorder—Vincristine—muscle cancer	0.00427	0.0045	CcSEcCtD
Travoprost—Fatigue—Vincristine—muscle cancer	0.00426	0.0045	CcSEcCtD
Travoprost—Hypertension—Etoposide—muscle cancer	0.00424	0.00447	CcSEcCtD
Travoprost—Constipation—Vincristine—muscle cancer	0.00423	0.00446	CcSEcCtD
Travoprost—Pain—Vincristine—muscle cancer	0.00423	0.00446	CcSEcCtD
Travoprost—Asthma—Methotrexate—muscle cancer	0.00422	0.00445	CcSEcCtD
Travoprost—Chest pain—Etoposide—muscle cancer	0.00418	0.00441	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00415	0.00438	CcSEcCtD
Travoprost—Discomfort—Etoposide—muscle cancer	0.00413	0.00435	CcSEcCtD
Travoprost—Hypersensitivity—Dactinomycin—muscle cancer	0.00408	0.0043	CcSEcCtD
Travoprost—Gastrointestinal pain—Vincristine—muscle cancer	0.00405	0.00427	CcSEcCtD
Travoprost—Infection—Etoposide—muscle cancer	0.00398	0.0042	CcSEcCtD
Travoprost—Asthenia—Dactinomycin—muscle cancer	0.00397	0.00419	CcSEcCtD
Travoprost—Dysuria—Methotrexate—muscle cancer	0.00395	0.00416	CcSEcCtD
Travoprost—Tachycardia—Etoposide—muscle cancer	0.00391	0.00412	CcSEcCtD
Travoprost—Abdominal pain—Vincristine—muscle cancer	0.00391	0.00412	CcSEcCtD
Travoprost—Skin disorder—Etoposide—muscle cancer	0.00389	0.0041	CcSEcCtD
Travoprost—Diarrhoea—Dactinomycin—muscle cancer	0.00379	0.00399	CcSEcCtD
Travoprost—Infestation NOS—Methotrexate—muscle cancer	0.00376	0.00397	CcSEcCtD
Travoprost—Infestation—Methotrexate—muscle cancer	0.00376	0.00397	CcSEcCtD
Travoprost—Depression—Methotrexate—muscle cancer	0.00375	0.00396	CcSEcCtD
Travoprost—Hypotension—Etoposide—muscle cancer	0.00374	0.00395	CcSEcCtD
Travoprost—Conjunctivitis—Methotrexate—muscle cancer	0.00366	0.00386	CcSEcCtD
Travoprost—Influenza—Doxorubicin—muscle cancer	0.00365	0.00385	CcSEcCtD
Travoprost—Asthma—Doxorubicin—muscle cancer	0.00365	0.00385	CcSEcCtD
Travoprost—Hypersensitivity—Vincristine—muscle cancer	0.00364	0.00384	CcSEcCtD
Travoprost—Dyspnoea—Etoposide—muscle cancer	0.00357	0.00377	CcSEcCtD
Travoprost—Angina pectoris—Doxorubicin—muscle cancer	0.00356	0.00375	CcSEcCtD
Travoprost—Asthenia—Vincristine—muscle cancer	0.00355	0.00374	CcSEcCtD
Travoprost—Bronchitis—Doxorubicin—muscle cancer	0.00351	0.00371	CcSEcCtD
Travoprost—Rash—Dactinomycin—muscle cancer	0.00349	0.00368	CcSEcCtD
Travoprost—Gastrointestinal disorder—Etoposide—muscle cancer	0.00346	0.00365	CcSEcCtD
Travoprost—Fatigue—Etoposide—muscle cancer	0.00345	0.00364	CcSEcCtD
Travoprost—Pain—Etoposide—muscle cancer	0.00343	0.00361	CcSEcCtD
Travoprost—Constipation—Etoposide—muscle cancer	0.00343	0.00361	CcSEcCtD
Travoprost—Dysuria—Doxorubicin—muscle cancer	0.00342	0.0036	CcSEcCtD
Travoprost—Diarrhoea—Vincristine—muscle cancer	0.00338	0.00357	CcSEcCtD
Travoprost—Pharyngitis—Methotrexate—muscle cancer	0.00335	0.00354	CcSEcCtD
Travoprost—Urinary tract disorder—Methotrexate—muscle cancer	0.00334	0.00352	CcSEcCtD
Travoprost—Urethral disorder—Methotrexate—muscle cancer	0.00331	0.00349	CcSEcCtD
Travoprost—Feeling abnormal—Etoposide—muscle cancer	0.0033	0.00348	CcSEcCtD
Travoprost—Nausea—Dactinomycin—muscle cancer	0.00329	0.00347	CcSEcCtD
Travoprost—Gastrointestinal pain—Etoposide—muscle cancer	0.00328	0.00346	CcSEcCtD
Travoprost—Dizziness—Vincristine—muscle cancer	0.00327	0.00345	CcSEcCtD
Travoprost—Infestation NOS—Doxorubicin—muscle cancer	0.00326	0.00344	CcSEcCtD
Travoprost—Infestation—Doxorubicin—muscle cancer	0.00326	0.00344	CcSEcCtD
Travoprost—Visual impairment—Methotrexate—muscle cancer	0.00326	0.00343	CcSEcCtD
Travoprost—Abdominal pain—Etoposide—muscle cancer	0.00317	0.00334	CcSEcCtD
Travoprost—Conjunctivitis—Doxorubicin—muscle cancer	0.00317	0.00334	CcSEcCtD
Travoprost—Urinary tract infection—Doxorubicin—muscle cancer	0.00317	0.00334	CcSEcCtD
Travoprost—Eye disorder—Methotrexate—muscle cancer	0.00316	0.00333	CcSEcCtD
Travoprost—Tinnitus—Methotrexate—muscle cancer	0.00315	0.00332	CcSEcCtD
Travoprost—Cardiac disorder—Methotrexate—muscle cancer	0.00314	0.00331	CcSEcCtD
Travoprost—Rash—Vincristine—muscle cancer	0.00312	0.00329	CcSEcCtD
Travoprost—Dermatitis—Vincristine—muscle cancer	0.00312	0.00329	CcSEcCtD
Travoprost—Headache—Vincristine—muscle cancer	0.0031	0.00327	CcSEcCtD
Travoprost—Angiopathy—Methotrexate—muscle cancer	0.00307	0.00323	CcSEcCtD
Travoprost—Sinusitis—Doxorubicin—muscle cancer	0.00306	0.00322	CcSEcCtD
Travoprost—Immune system disorder—Methotrexate—muscle cancer	0.00305	0.00322	CcSEcCtD
Travoprost—Mediastinal disorder—Methotrexate—muscle cancer	0.00304	0.00321	CcSEcCtD
Travoprost—Bradycardia—Doxorubicin—muscle cancer	0.00298	0.00314	CcSEcCtD
Travoprost—Mental disorder—Methotrexate—muscle cancer	0.00296	0.00312	CcSEcCtD
Travoprost—Hypersensitivity—Etoposide—muscle cancer	0.00295	0.00311	CcSEcCtD
Travoprost—Erythema—Methotrexate—muscle cancer	0.00294	0.0031	CcSEcCtD
Travoprost—Nausea—Vincristine—muscle cancer	0.00294	0.0031	CcSEcCtD
Travoprost—Rhinitis—Doxorubicin—muscle cancer	0.00293	0.00309	CcSEcCtD
Travoprost—Pharyngitis—Doxorubicin—muscle cancer	0.0029	0.00306	CcSEcCtD
Travoprost—Urinary tract disorder—Doxorubicin—muscle cancer	0.00289	0.00305	CcSEcCtD
Travoprost—Dysgeusia—Methotrexate—muscle cancer	0.00288	0.00304	CcSEcCtD
Travoprost—Asthenia—Etoposide—muscle cancer	0.00288	0.00303	CcSEcCtD
Travoprost—Connective tissue disorder—Doxorubicin—muscle cancer	0.00287	0.00303	CcSEcCtD
Travoprost—Urethral disorder—Doxorubicin—muscle cancer	0.00287	0.00302	CcSEcCtD
Travoprost—Back pain—Methotrexate—muscle cancer	0.00284	0.003	CcSEcCtD
Travoprost—Pruritus—Etoposide—muscle cancer	0.00284	0.00299	CcSEcCtD
Travoprost—Visual impairment—Doxorubicin—muscle cancer	0.00282	0.00297	CcSEcCtD
Travoprost—Vision blurred—Methotrexate—muscle cancer	0.00277	0.00292	CcSEcCtD
Travoprost—Diarrhoea—Etoposide—muscle cancer	0.00274	0.00289	CcSEcCtD
Travoprost—Eye disorder—Doxorubicin—muscle cancer	0.00273	0.00288	CcSEcCtD
Travoprost—Ill-defined disorder—Methotrexate—muscle cancer	0.00273	0.00288	CcSEcCtD
Travoprost—Tinnitus—Doxorubicin—muscle cancer	0.00273	0.00288	CcSEcCtD
Travoprost—Cardiac disorder—Doxorubicin—muscle cancer	0.00271	0.00286	CcSEcCtD
Travoprost—Angiopathy—Doxorubicin—muscle cancer	0.00265	0.0028	CcSEcCtD
Travoprost—Malaise—Methotrexate—muscle cancer	0.00265	0.0028	CcSEcCtD
Travoprost—Dizziness—Etoposide—muscle cancer	0.00265	0.00279	CcSEcCtD
Travoprost—Immune system disorder—Doxorubicin—muscle cancer	0.00264	0.00279	CcSEcCtD
Travoprost—Vertigo—Methotrexate—muscle cancer	0.00264	0.00279	CcSEcCtD
Travoprost—Mediastinal disorder—Doxorubicin—muscle cancer	0.00264	0.00278	CcSEcCtD
Travoprost—Cough—Methotrexate—muscle cancer	0.00257	0.00271	CcSEcCtD
Travoprost—Mental disorder—Doxorubicin—muscle cancer	0.00256	0.0027	CcSEcCtD
Travoprost—Erythema—Doxorubicin—muscle cancer	0.00255	0.00269	CcSEcCtD
Travoprost—Rash—Etoposide—muscle cancer	0.00253	0.00266	CcSEcCtD
Travoprost—Dermatitis—Etoposide—muscle cancer	0.00252	0.00266	CcSEcCtD
Travoprost—Headache—Etoposide—muscle cancer	0.00251	0.00265	CcSEcCtD
Travoprost—Arthralgia—Methotrexate—muscle cancer	0.0025	0.00264	CcSEcCtD
Travoprost—Chest pain—Methotrexate—muscle cancer	0.0025	0.00264	CcSEcCtD
Travoprost—Myalgia—Methotrexate—muscle cancer	0.0025	0.00264	CcSEcCtD
Travoprost—Dysgeusia—Doxorubicin—muscle cancer	0.00249	0.00263	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00249	0.00262	CcSEcCtD
Travoprost—Discomfort—Methotrexate—muscle cancer	0.00247	0.00261	CcSEcCtD
Travoprost—Back pain—Doxorubicin—muscle cancer	0.00246	0.0026	CcSEcCtD
Travoprost—Vision blurred—Doxorubicin—muscle cancer	0.0024	0.00253	CcSEcCtD
Travoprost—Infection—Methotrexate—muscle cancer	0.00238	0.00251	CcSEcCtD
Travoprost—Nausea—Etoposide—muscle cancer	0.00238	0.00251	CcSEcCtD
Travoprost—Ill-defined disorder—Doxorubicin—muscle cancer	0.00236	0.00249	CcSEcCtD
Travoprost—Nervous system disorder—Methotrexate—muscle cancer	0.00235	0.00248	CcSEcCtD
Travoprost—Skin disorder—Methotrexate—muscle cancer	0.00233	0.00246	CcSEcCtD
Travoprost—Malaise—Doxorubicin—muscle cancer	0.0023	0.00242	CcSEcCtD
Travoprost—Vertigo—Doxorubicin—muscle cancer	0.00229	0.00241	CcSEcCtD
Travoprost—Palpitations—Doxorubicin—muscle cancer	0.00225	0.00237	CcSEcCtD
Travoprost—Hypotension—Methotrexate—muscle cancer	0.00224	0.00236	CcSEcCtD
Travoprost—Cough—Doxorubicin—muscle cancer	0.00222	0.00234	CcSEcCtD
Travoprost—Hypertension—Doxorubicin—muscle cancer	0.0022	0.00232	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00219	0.00231	CcSEcCtD
Travoprost—Arthralgia—Doxorubicin—muscle cancer	0.00217	0.00229	CcSEcCtD
Travoprost—Chest pain—Doxorubicin—muscle cancer	0.00217	0.00229	CcSEcCtD
Travoprost—Myalgia—Doxorubicin—muscle cancer	0.00217	0.00229	CcSEcCtD
Travoprost—Anxiety—Doxorubicin—muscle cancer	0.00216	0.00228	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00215	0.00227	CcSEcCtD
Travoprost—Discomfort—Doxorubicin—muscle cancer	0.00214	0.00226	CcSEcCtD
Travoprost—Dyspnoea—Methotrexate—muscle cancer	0.00214	0.00226	CcSEcCtD
Travoprost—Dry mouth—Doxorubicin—muscle cancer	0.00212	0.00224	CcSEcCtD
Travoprost—Dyspepsia—Methotrexate—muscle cancer	0.00211	0.00223	CcSEcCtD
Travoprost—Oedema—Doxorubicin—muscle cancer	0.00208	0.00219	CcSEcCtD
Travoprost—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00207	0.00219	CcSEcCtD
Travoprost—Fatigue—Methotrexate—muscle cancer	0.00207	0.00218	CcSEcCtD
Travoprost—Infection—Doxorubicin—muscle cancer	0.00206	0.00218	CcSEcCtD
Travoprost—Pain—Methotrexate—muscle cancer	0.00205	0.00216	CcSEcCtD
Travoprost—Nervous system disorder—Doxorubicin—muscle cancer	0.00204	0.00215	CcSEcCtD
Travoprost—Tachycardia—Doxorubicin—muscle cancer	0.00203	0.00214	CcSEcCtD
Travoprost—Skin disorder—Doxorubicin—muscle cancer	0.00202	0.00213	CcSEcCtD
Travoprost—Feeling abnormal—Methotrexate—muscle cancer	0.00198	0.00209	CcSEcCtD
Travoprost—Gastrointestinal pain—Methotrexate—muscle cancer	0.00196	0.00207	CcSEcCtD
Travoprost—Hypotension—Doxorubicin—muscle cancer	0.00194	0.00205	CcSEcCtD
Travoprost—Abdominal pain—Methotrexate—muscle cancer	0.0019	0.002	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00189	0.002	CcSEcCtD
Travoprost—Dyspnoea—Doxorubicin—muscle cancer	0.00185	0.00195	CcSEcCtD
Travoprost—Dyspepsia—Doxorubicin—muscle cancer	0.00183	0.00193	CcSEcCtD
Travoprost—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00179	0.00189	CcSEcCtD
Travoprost—Fatigue—Doxorubicin—muscle cancer	0.00179	0.00189	CcSEcCtD
Travoprost—Constipation—Doxorubicin—muscle cancer	0.00178	0.00187	CcSEcCtD
Travoprost—Pain—Doxorubicin—muscle cancer	0.00178	0.00187	CcSEcCtD
Travoprost—Hypersensitivity—Methotrexate—muscle cancer	0.00177	0.00186	CcSEcCtD
Travoprost—Asthenia—Methotrexate—muscle cancer	0.00172	0.00182	CcSEcCtD
Travoprost—Feeling abnormal—Doxorubicin—muscle cancer	0.00171	0.00181	CcSEcCtD
Travoprost—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0017	0.00179	CcSEcCtD
Travoprost—Pruritus—Methotrexate—muscle cancer	0.0017	0.00179	CcSEcCtD
Travoprost—Abdominal pain—Doxorubicin—muscle cancer	0.00164	0.00173	CcSEcCtD
Travoprost—Diarrhoea—Methotrexate—muscle cancer	0.00164	0.00173	CcSEcCtD
Travoprost—Dizziness—Methotrexate—muscle cancer	0.00159	0.00167	CcSEcCtD
Travoprost—Hypersensitivity—Doxorubicin—muscle cancer	0.00153	0.00161	CcSEcCtD
Travoprost—Rash—Methotrexate—muscle cancer	0.00151	0.0016	CcSEcCtD
Travoprost—Dermatitis—Methotrexate—muscle cancer	0.00151	0.00159	CcSEcCtD
Travoprost—Headache—Methotrexate—muscle cancer	0.0015	0.00159	CcSEcCtD
Travoprost—Asthenia—Doxorubicin—muscle cancer	0.00149	0.00157	CcSEcCtD
Travoprost—Pruritus—Doxorubicin—muscle cancer	0.00147	0.00155	CcSEcCtD
Travoprost—Nausea—Methotrexate—muscle cancer	0.00143	0.0015	CcSEcCtD
Travoprost—Diarrhoea—Doxorubicin—muscle cancer	0.00142	0.0015	CcSEcCtD
Travoprost—Dizziness—Doxorubicin—muscle cancer	0.00137	0.00145	CcSEcCtD
Travoprost—Rash—Doxorubicin—muscle cancer	0.00131	0.00138	CcSEcCtD
Travoprost—Dermatitis—Doxorubicin—muscle cancer	0.00131	0.00138	CcSEcCtD
Travoprost—Headache—Doxorubicin—muscle cancer	0.0013	0.00137	CcSEcCtD
Travoprost—Nausea—Doxorubicin—muscle cancer	0.00123	0.0013	CcSEcCtD
